Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Combined Treatment of Surgery and Liraglutide on Glycemic Variability and Control in Type 2 Diabetes Mellitus
2014-000397-19Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and class III obesity comparing Liraglutide with Placebo (2 arms). Primary endpoints: Glycemic variability and Glycemic control. Started Sep 2014; status: active.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)class III obesity
Beyond the preview
Go deeper on 2014-000397-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000397-19.